News
-
-
-
-
PRESS RELEASE
The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation
CMS revises National Coverage Determination for allogeneic HSCT in MDS patients following requests from ASH, ASTCT, NMDP, and CIBMTR. Updated ruling expands Medicare coverage for life-saving treatment -
-
-
-
PRESS RELEASE
ASTCT to Present Distinguished Honors at the 2024 Tandem Meetings
ASTCT presents top awards to leaders in transplantation and cellular therapy at the Tandem Meetings in San Antonio. Dr. Gerard Socie receives the 2024 Lifetime Achievement Award for his research on Graft-versus-host disease -
PRESS RELEASE
ASTCT Supports the FDA’s Accelerated Approval of AMTAGVI for Treatment of Metastatic Melanoma
The American Society for Transplantation and Cellular Therapy supports FDA's accelerated approval of lifileucel for unresectable or metastatic melanoma, offering new hope in solid tumor cancer treatment -
PRESS RELEASE
American Society for Transplantation and Cellular Therapy Awards Robin Roberts With the 2024 Public Service Award
The American Society for Transplantation and Cellular Therapy will honor Robin Roberts with the 2024 Public Service Award for her advocacy in raising awareness for bone stem cell transplant and advancing breakthroughs in HCT and cell therapy
-
LaMar’s Donuts Celebrates National Donut Day 2024
-
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
-
abrdn Income Credit Strategies Fund Announces Update and Tentative Closing Date for Acquisition of Assets From First Trust High Income Long/Short Fund
-
Electric Royalties Announces Interest Conversion Under Convertible Credit Facility
-
Pfister Faucets' American Plumber Stories Docuseries Wins Three Telly Awards
-
EQS-Adhoc: Vectron Systems AG: Vectron enters into Business Combination Agreement, resolves 10% capital increase without subscription rights of the shareholders and supports voluntary public acqusition offer
-
CPI PROPERTY GROUP publishes financial results for the first quarter of 2024
-
Leclanché SA: Publishes its Annual Report 2023 and Non-financial ESG Report
-
Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM.
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
ACCOR - Description of own share buyback programme
-
ACCOR - Press release following the 2024 general meeting
-
Capital increase through exercise of subscription rights
-
NFL BIOSCIENCES: RESULTS OF THE COMBINED GENERAL MEETING OF MAY 30, 2024
-
Thales has completed the sale of its Ground Transportation Systems business